
HPV vaccine could prevent thousands of cervical cancer cases each year. A doctor explains
Every year, there are an estimated 48,000 new cases of cancers associated with the human papillomavirus, or HPV, in the United States, according to the US Centers for Disease Control and Prevention. But in the case of HPV, there actually is a vaccine.
Yet public awareness remains low. Over one-third of American adults are unaware of HPV or the HPV vaccine, according to a new research letter published Thursday in JAMA Oncology. In some states, the numbers are significantly higher.
That's why people need to know about HPV, the cancers linked to the virus, and the effectiveness of the HPV vaccine.
To help with these questions, I spoke with CNN wellness expert Dr. Leana Wen. Wen is an emergency physician and adjunct associate professor at George Washington University. She previously was Baltimore's health commissioner, and she is the mother of two young children.
CNN: What is HPV, and what cancers is it linked to?
Dr. Leana Wen: HPV is a virus that can infect humans. There are over 100 types of HPV. Most HPV infections aren't linked to cancer, but some are. The specific types of cancers associated with HPV infection are cervical cancer, cancers of the vagina, vulva, penis and anus. Some oral and throat cancers are also associated with HPV infection.
Of the cancers linked to HPV, cervical cancer is the most common. Each year in the US, there are about 13,000 new cases of cervical cancer. About 4,000 American women die of this cancer annually. However, as referenced in the new report, it's not just cervical cancer — there are as many as 48,000 new cancer diagnoses linked annually to HPV. It's important for people to understand the association between HPV and cervical cancer as well as the link to other cancer types, including the link to oropharyngeal cancers.
CNN: Do people know if they have HPV — do they have symptoms at the time?
Wen: Some types of HPV cause warts. These tend to be what's called low-risk HPV, meaning HPV that is not linked with cancer. Infections with high-risk HPV do not cause symptoms at the time of infection; symptoms can develop later when precancerous and cancerous cells develop.
According to the National Cancer Institute, HPV infection is very common — so common that nearly all sexually active people become infected with HPV within a few years of becoming sexually active. As much as half of HPV infections involve high-risk HPV.
Most HPV infections are cleared by the body and do not result in cancer. However, some high-risk infections can persist. Over the course of many years, it can lead to the development of precancerous and then cancerous cells.
CNN: How is HPV spread?
Wen: The most common way for HPV to spread is through sexual intercourse. The virus can also spread during close skin-to-skin contact during intercourse.
It's crucial to understand just how widespread HPV is and how high-risk HPV is spread by asymptomatic people. Condoms can lower the risk of spreading HPV, but because HPV can infect areas that condoms don't cover, they don't fully protect against HPV. This is why vaccination is so important, to protect against HPV-causing cancers down the line.
CNN: How effective is the HPV vaccine?
Wen: The HPV vaccines have very high efficacy — close to 100% — for the prevention of cervical cancer in women, according to the CDC. The vaccines have also been found to have very high efficacy in men who have sex with men in preventing anal cancer. The vaccines also reduce the likelihood of developing genital warts.
CNN: When is the vaccine recommended to be given?
Wen: The CDC recommends that preteens receive the first dose of the vaccine at age 11 or 12, though it can be given as early as age 9. For most people 9 through 14, a two-dose series is recommended, with the second shot given six to 12 months after the first. A three-dose series is recommended for people who begin vaccination at ages 15 through 45 and for immunocompromised individuals. The second shot is given one to two months after the first and the third about five months later.
CNN: I have heard some parents say that they don't want their children to get the shot because it may encourage them to have sex earlier. How do doctors and public health experts respond to that concern?
Wen: They would point to the data. A large study published in the journal JAMA Internal Medicine compared over 21,000 vaccinated girls with nearly 186,000 unvaccinated peers and found 'no evidence of increased unsafe sexual behavior.' Other studies have found no association between HPV vaccination status and age of first sexual encounter or number of sexual partners.
Because high-risk HPV is so widespread, protecting against the cancers it can cause is essential. We are fortunate to have a vaccine that is so effective. Giving the vaccine is not about encouraging a particular behavior, but about giving protection in case someone becomes exposed to a virus someday.
CNN: What is your takeaway from this latest report?
Wen: Awareness of HPV and the HPV vaccine remains dangerously low among the general public. In seven states, more than 40% of adults were not aware of HPV; in 13 states, more than 40% were unaware of the vaccine. In 45 states and Washington, DC, more than 60% did not know that HPV could cause oral cancers.
The authors concluded that 'there is a critical need to enhance HPV awareness among adolescents, young adults, parents or caregivers, and pediatric and adult health care professionals.' I agree.
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
35 minutes ago
- New York Post
The ‘Nordic diet' can help you lose weight and prevent heart attacks — stock up on these foods
Forget the Mediterranean — the land of snow and salmon is serving up a fresh way to eat that gives your heart a healthy boost. A growing body of research suggests the Nordic diet can help trim your waist, tame your cholesterol levels and keep your blood pressure in check. That could be a game-changer in the fight against cardiovascular disease, which kills an American every 34 seconds. 4 The Nordic diet is packed with fiber, fatty fish and cold-weather produce. Getty Images This northern European way of eating leans heavily on whole foods that retain their natural nutrients, in sharp contrast to the US food supply, where up to 70% is ultraprocessed. It revolves around seasonal, locally sourced ingredients found across Nordic nations like Denmark, Finland, Iceland, Norway and Sweden. '[The Vikings] were limited to the foods available to them at the time,' Lauren Harris-Pincus, a registered dietitian, told Fox News. 'Their diet focused on clean, sustainable foods, which is why we are discussing its health benefits today.' Like the Mediterranean diet — long hailed for its heart-healthy power — the Nordic style is plant-forward, high in fiber and packed with seafood. 4 Fatty fish are excellent sources of omega-3 fatty acids, which are linked to reduced risk of heart disease. artemidovna – But while the Greeks rely on olive oil, the northern approach leans on rapeseed (or canola) oil, another heart-friendly monounsaturated fat, according to Harvard Health. Rapeseed oil is also a source of alpha-linolenic acid, a plant-based omega-3 fatty acid similar to the kind found in fatty fish like salmon, mackerel, sardines and herring — all staples of the Nordic kitchen. Followers typically eat two to three servings of these fish each week. The omega-3s delivered by both the oil and fish have been shown to reduce the risk of heart rhythm issues, slow plaque buildup in arteries and lower fat levels in the blood, key factors in protecting cardiovascular health. The Nordic diet also emphasizes low-fat dairy, such as yogurt, and incorporates eggs and poultry in moderation. Red and processed meats, on the other hand, rarely make it onto the plate. 4 Root vegetables are loaded with vitamins, minerals, antioxidants and fiber. Viktor Iden – Whole grains such as oats, barley and rye are another cornerstone in this eating pattern. These fiber-rich 'complex' carbs digest slowly, helping to curb cravings and keep blood sugar steady — unlike refined grains in processed staples like white bread. Cold-weather veggies like turnips, carrots, parsnips, cabbage and cauliflower are also featured prominently. They're packed with fiber and nutrients that have been shown to help lower cholesterol and blood pressure. Berries like blueberries, strawberries, cranberries and lingonberries play a starring role, too. Rich in antioxidants called anthocyanins, these fruits help keep arteries flexible and may also lower blood pressure. Unlike many American eating habits, the Nordic diet also goes easy on alcohol and avoids foods high in added sugar and sodium. By avoiding processed junk, saturated fats and high-cholesterol meats while loading up on fiber-rich whole foods, studies suggest the Nordic diet can lead to significant weight loss — a major win for heart health. 4 Every year, about 805,000 people in the US have a heart attack. Pixel-Shot – In one study, people who followed the Nordic diet for just six weeks lost 4% of their body weight — significantly more than those eating a standard western diet. In another trial, people with obesity who stuck to it for six months dropped about 10 pounds — roughly triple the weight loss seen in a typical diet group. And it's not just about the scale. In a 2022 analysis, researchers found that the Nordic diet helped lower cholesterol and blood sugar levels independent of weight loss. 'The group that had been on the Nordic diet for six months became significantly healthier, with lower cholesterol levels, lower overall levels of both saturated and unsaturated fat in the blood, and better regulation of glucose, compared to the control group,' study author Lars Ove Dragsted said in a statement. Other studies have found that the Nordic diet can have a positive impact on blood pressure and inflammation. Taken together, and experts say this cold-climate cuisine could be just what the doctor ordered for your heart. A 2023 review even found that the Nordic diet might reduce the risk of death from cardiovascular disease, the leading cause of death in the US. However, more research is needed to nail down exactly how much. Still, experts say Americans could learn a thing or two from their northern neighbors — especially when it comes to cutting processed meats and sugar-laden snacks. 'People who really like berries, rye bread, and canola oil should go ahead and enjoy a Nordic-style diet rather than waiting 10 years to get more evidence,' advised Dr. Frank Hu, professor of nutrition at the Harvard TH Chan School of Public Health.


New York Post
3 hours ago
- New York Post
Rehab can keep you out of jail — but become a prison itself
Chris Koon didn't read the fine print. Sitting in the Cenikor Baton Rouge rehab center's intake office in 2015, flanked by his mom and grandmother, he signed where told. 'A lot of it read like legalese,' writes Shoshana Walter in 'Rehab: An American Scandal' (Simon & Schuster, Aug. 12). 'Incomprehensible but also innocuous, like something you might see before downloading an app on your phone.' Koon felt lucky. He wasn't going to prison. Just days earlier, he'd been arrested for meth possession. The alternative to five years in state prison? A brutal two-year Cenikor inpatient program. Koon took the deal. In signing the intake documents, he agreed to 'receive no monetary compensation' for work he did, with wages going 'directly back to the Foundation.' He signed away his right to workers' compensation if injured. He forfeited his food stamps, disability payments and any other government assistance. And he agreed to 'adopt appropriate morals and values as promoted by the program.' Koon's story isn't an outlier — it's a glimpse into what Walter calls 'America's other drug crisis.' While overdoses and opioid deaths dominate headlines, far less attention goes to the 'profit-hungry, under-regulated, and all too often deadly rehab industry,' writes Walter. Across the country, thousands of treatment programs are propped up by federal policies and rooted in a distinctly American blend of punishment and personal responsibility. People were 'lured to rehab with the promise of a cure for what ailed them,' Walter writes, 'only to repeatedly falter and fail inside a system that treated them like dollar signs.' The idea hard labor can cure someone isn't new. After the Civil War, US slavery was abolished except as punishment for a crime. That loophole became the foundation for a forced-labor system that conveyed newly freed black people into prisons and chain gangs. Over time, prison officials began marketing this arrangement as 'rehabilitation.' As Walter writes, this legacy has been repackaged for the modern drug crisis. The Affordable Care Act promised expanded treatment access through Medicaid. But the rehab industry that exploded in response was lightly regulated, profit-driven and increasingly dangerous. The result: thousands of people like Chris Koon, lured into treatment by courts, cops or family members, only to find themselves stuck in a system that looked less like therapy and more like punishment. They include women like April Lee, a black woman from Philadelphia. Despite growing up in addiction's long shadow — her mother died from AIDS when Lee was just a teenager, after years of selling sex to support a crack habit — Lee didn't start using drugs herself until after having her second child, when a doctor prescribed her Percocet for back pain. That opened the door to addiction. Child-welfare authorities eventually took her kids. Fellow users nicknamed her 'Mom' and 'Doc' for her uncanny ability to find usable veins, no matter how damaged. April Lee returned to her recovery house — as an unpaid house monitor. April Lee / ACLU She entered recovery in 2016. Every morning at 6, 18 women gathered in the dining room of one of two overcrowded houses to read from the Bible. Lee stayed 10 months. With nowhere else to go, she returned — this time as a house monitor, working without pay in exchange for a bed. 'She was still early into recovery, and she felt stressed by the intensity of the job,' Walter writes. 'On top of that, she wasn't getting a paycheck, so she couldn't save up money to leave.' 'Don't really know how to feel right now,' Lee wrote in her journal. 'The lady I work for — for free, mind you — wont me to watch over women witch mean I have to stay in every night.' She felt physically and emotionally trapped. 'I wanted to snap this morning. Miss my children so much.' Like so many others, Lee found herself stuck in the recovery-house loop — forced to work, unable to leave and earning nothing. She helped with chores, mainly cooking and cleaning. Residents' food stamps stocked the kitchen. Lee loved to cook, and she made comfort food for the house: mac and cheese, fried chicken, beef stew. But all the warmth she gave others couldn't buy her a way out. For others, like Koon, it was about more than just forced labor. During his first 30 days at Cenikor, the other patients policed each other. If one person broke a rule, the entire group might be punished with a 'fire drill' in the middle of the night. 'If anyone stepped out of line or did something wrong during the drill, they'd have to stay awake even longer,' Walter writes. Discipline was obsessive. In his first month, Koon sat in a classroom with about 30 other residents, most sent by courts like he was, reciting rules out loud, line by line. There were more than 100. 'He could get in trouble for not having a pen, not wearing a belt, for an untied shoelace, for leaving a book on the table, for his shirt coming untucked,' Walter details. Koon learned the punishment system fast. A common one was 'the verbal chair,' in which any participant could order him to sit, arms locked and knees at a 90-degree angle, and stare silently at the wall while others screamed at him. 'Go have a seat in the verbal chair. Think about having your shirt untucked,' they'd say. And Koon, like everyone else, was expected to respond, 'Thank you.' There were others. 'Mirror therapy,' where he'd stand and yell his failings at himself in the mirror. 'The dishpan,' where he'd be dressed in a neon-green shirt, scrubbing floors and dishes while loudly reciting the Cenikor philosophy, 'a paragraph-long diatribe about self-change,' Walter writes. And the dreaded 'verbal haircut,' when another resident, sometimes even a staff member, would berate him as part of his treatment. Dressed up as a therapeutic community, Koon thought instead, 'This is like a cult.' Walter believes he wasn't far off. Everyone was required to tattle. Koon had to turn in weekly at least 10 'pull-ups' — written reports detailing rule infractions committed by fellow residents. If he didn't, he could lose points and with them privileges like phone calls, family visits or permission to grow a mustache. Confrontations were public and ritualized: Residents would sit in a circle around one or two people forced to listen as everyone else denounced them. 'They took turns confronting that person, professing their faults and errors, while the person was permitted only to say 'thank you,'' Walter writes. Staff called it 'The Game.' He saw grown men cry. He heard women called bitches and sluts. He realized many employees were former participants enforcing the system that once broke them. Not everyone saw a problem. Many in the legal system embraced tough-love rehab programs, especially judges looking for alternatives to jail. One of Cenikor's biggest champions was Judge Larry Gist, who ran one of the first drug courts, in Jefferson County, Texas, in the 1990s. 'The vast majority of folks that I deal with are basically bottom-feeders,' Gist told the author. 'They've been losers since the day they were born.' Cenikor's extreme model was ideal for 'the right people,' he believed. Cenikor rewarded such loyalty, giving judges and lawmakers steak dinners served by participants and annual awards banquets, complete with gleaming, diamond-shaped trophies. Gist 'proudly displayed his' in 'his chambers, where he liked to host his happy hours with prosecutors and defense attorneys.' Koon was booted out of Cenikor after just two years, for faking a urine sample and contracting a contagious staph infection, but managed to stay sober on his own. He proposed to his childhood sweetheart, Paige, moving in with her two daughters, and finding the stability he'd been chasing for years. He went back to school to learn welding, and the daily rhythms of family life kept him grounded. 'He hasn't taken a drug recreationally for eight years,' Walter writes. Lee's path out took longer, and her recovery was, as Walter writes, 'in some ways a stroke of luck.' She left the house after landing a job at a law firm that helped women reunite with their children in foster care — a world away from the nights she'd once spent tricking at the Blue Moon Hotel but one that barely covered her bills and pushed her just over the poverty line, cutting off assistance. She earned her GED, took online college courses, regained custody of her kids and bought her own home by 2021. 'And yet many days she felt she was teetering on the edge, one crisis or unpaid bill away from making a terrible mistake,' Walter writes. That year, she returned to Kensington, where her addiction had once thrived, bringing fresh food and water to people still living on the streets. As for Cenikor, its time in the shadows ended, at least temporarily. Investigators found evidence of exploitation: residents forced to work without pay, unsafe housing conditions, staff-client relationships, even overdoses inside the facilities. The state of Texas fined Cenikor more than $1.4 million in 2019, but the agency struck a settlement, and it continued to operate. Koon and Lee don't represent everyone who's experienced addiction, treatment or recovery. But they do reflect a system that often promises far more than it delivers. 'When rehab works, it can save lives,' Walter writes. 'It can mend families and be among the most redemptive narrative arcs in a person's life.' But sometimes, rehab not only fails to help people, it actively harms them, recycling them through a gauntlet of relapse, shame and risk: 'Despite the rehab industry's many claims, there is no magical cure for addiction.'
Yahoo
5 hours ago
- Yahoo
Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news involving Precigen and Pfizer, as well as updates from the Institute for Clinical and Economic Review, Superluminal Medicines and Generation Bio that you may have missed. The Food and Drug Administration granted full approval to a first-of-its-kind treatment for recurrent respiratory papillomatosis, a rare and potentially life-threatening condition caused by persistent HPV infections. Thursday's clearance of Precigen's Papzimeos, an immunotherapy that helps clear HPV-infected cells, was based on study results showing a little more than half of drug recipients didn't need surgery within a year of therapy. Center for Biologics Evaluation and Research director Vinay Prasad, who rejoined the FDA this week, described the approval as proof 'randomized trials are not always needed to approve medical products.' That statement should be 'reassuring' to biotech investors concerned about stricter regulatory standards under Prasad, wrote Cantor Fitzgerald analyst Jennifer Kim. Precigen shares rose higher Friday on the news. — Ben Fidler An experimental Pfizer drug for sickle cell disease failed to meet its goal in a Phase 3 study, the company said Friday. Testing showed that treatment with inclacumab, a drug Pfizer acquired via its 2022 buyout of Global Blood Therapeutics, failed to significantly reduce versus placebo the pain crises people with sickle cell often experience. Pfizer said it would share analyses of the data with the scientific and patient community in 'due course.' Last year, the company pulled from market another sickle cell drug, Oxbryta, that it gained from Global Blood, citing safety concerns. The company plans to provide updates on Oxbryta and a third Global Blood drug, the experimental osivelotor, when they become available. — Ned Pagliarulo Eli Lilly will collaborate with biotechnology startup Superluminal Medicines to develop new drugs for cardiometabolic diseases and obesity. Through the alliance, the two intend to discover and advance small molecule medicines aimed at undisclosed G protein-coupled receptor, or GPCR, targets 'relevant' to those conditions. Lilly will receive exclusive rights to the compounds emerging from the deal, while Superluminal could get up to $1.3 billion in total payouts, including an unspecified upfront payment as well as an equity investment, the companies said Thursday. — Ben Fidler Autolus Therapeutics is delaying launching its leukemia cell therapy Aucatzyl in Europe following approval there as the company 'evaluates potential pricing and feasibility of market entry opportunities' in some countries. Launch in Germany is on hold and Autolus 'does not anticipate any EU sales of Aucatzyl in 2025 and 2026,' the company said in its second quarter earnings report. In the U.K., where Aucatzyl has also been approved, a government cost-effectiveness monitor has initially decided not to pay for it. Autolus said it 'will continue to work towards a pathway for patient access to therapy in the U.K.' Approved by the Food and Drug Administration in November 2024, Aucatzyl earned just shy of $30 million in sales in the first six months of 2025, all from the U.S. — Jonathan Gardner Generation Bio revealed preclinical results suggesting a delivery technology it's developing can effectively send nucleic acid payloads into T cells. But the company also said this week that it may not be able to raise the funds to prove that approach works in humans and, as a result, began a strategic review that could end in a sale or merger. Generation will lay off roughly 90% of its workforce, including all of its research and development staff, by the end of October. Company shares climbed 60%, though they've lost much of their value since the company's initial public offering in 2020. — Ben Fidler Recommended Reading Eli Lilly's Julie Gilmore on finding up-and-coming companies and backing small biotechs Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data